The history of Flaraxin
 
The preparation “Flaraxin” was first studied in the period from 1985 to 1990.
According to the data of the preparation clinical trial it was established that “Flaraxin” is a remedy of vegetable origin, active components of which are vegetable polyphenoles. During the trial it was found out that “Flaraxin” has the ability to stimulate the secretion of endogenic interferon and the neoplasm necrosis factor, promotes immunologic background normalization and smoothes out the correlation of immunocomponent cells CD4/CD8 (helpers-suppressors) and increases the number of natural killers (NKcells).
During the immune-biochemical trial the ability of “Flaraxin” to connect with oncophetal proteins, causing their micro-denaturation damages was established. Cancerostatic effect was explicated by “Flaraxin” influence on metabolism of neoplasm cells, causing their death.
Clinical trial of the preparation “Flaraxin” was carried out on the basis of oncology department of Kiev medical institute in the period from September 1990 to January 1991 and in Kiev Oncology SRI under oncologic process in the stage of neglect desolation in patients with melanoblastoma in the period from December 1992 to October 1993.
Stccc Phoenix is looking for doctors and medical centers around the world to work together ,to bring cancer into absolute remission ?
You can contact us: Contact information 
SCIENTIFIC & TREATMENT CENTER FOR CANCER CURING PHOENIX
(License of the Ukrainian Ministry of Health Seria АБ №299302)
Contact adres: Svobody sq. 7, office 378, 61022-Kharkiv, Ukraine
Tel: +38 (067) 571 77 64  E-mail : stccc.phoenix.ua@gmail.com